Prednisolone Acetate Ophthalmic Suspension Usp (Prednisolone Acetate Ophthalmic Suspension Usp) is a commonly used ophthalmic drug, but it is also accompanied by many side effects, which cannot be ignored.

Its side effects are first seen in the eye. After treatment, some patients may feel eye discomfort, such as increased intraocular pressure. If this disease is not detected and treated in time, long-term high intraocular pressure can cause optic nerve damage, which in turn affects vision, and even blindness in severe cases. And the eye is prone to infection, because the drug inhibits the body's immune response, weakens the eye's ability to resist germs, allowing the originally hidden pathogens to breed, or aggravates eye inflammation, such as bacterial, fungal or viral keratitis.

Systemic, there is also latent risk. Prednisolone acetate ophthalmic suspension is absorbed locally through the eyes, or enters the blood circulation and affects the whole body. Long-term use can cause endocrine disorders, interfere with the balance of hormones in the body, and especially inhibit the function of the adrenal cortex. If used in children, it may also affect growth and development, because hormones can interfere with the secretion and action of growth hormone, hindering bone growth and physical development.

In addition, allergic reactions also occur from time to time. Some individuals are allergic to the drug ingredients. After taking the drug, eye itching, redness and swelling may occur. In severe cases, there may be symptoms such as rash and shortness of breath all over the body, which endanger life and health.

Therefore, when using prednisolone acetate ophthalmic suspension clinically, physicians should weigh the pros and cons, closely monitor the patient's condition, and ensure that the medication is safe and effective. Patients also need to strictly follow the doctor's instructions and do not increase or decrease the dose or stop the medication without authorization. If they feel unwell, seek medical attention in time.